Anuloma Viloma TimerA randomised controlled trial published in 2025 in BMC Complementary Medicine and Therapies has done something the wellness writeups about breathwork rarely do. It recommended pranayama not as a complementary therapy, not as a yoga supplement, but as an independent nursing intervention for a specific clinical population.
The population was women undergoing chemotherapy for breast cancer. The recommendation came from the trial authors, not from a yoga teacher writing a magazine essay. That distinction matters, and it is the reason this paper is worth reading carefully.
What the study did
The trial enrolled 76 women receiving chemotherapy for breast cancer at a tertiary care hospital. The participants were randomised into two groups. The pranayama group practised twice daily, ten minutes per session, for 21 days. The control group received routine chemotherapy care. The primary outcome was symptom burden, measured using the MD Anderson Symptom Inventory, a validated 19-item scale that covers fatigue, pain, nausea, sleep disturbance, distress, and the other recognisable companions of cancer treatment.
The pranayama group’s symptom burden dropped significantly versus controls. The reduction was not a soft self-report on mood. It was a measurable change on a scale that oncology clinicians already use to track how a treatment cycle is going.
The authors’ conclusion is the line worth highlighting. They recommend pranayama as an independent nursing intervention.
A companion scoping review in Wiley Lifestyle Medicine looked across all breathwork randomised controlled trials in women with breast cancer and reached the same broad conclusion: the evidence is consistent enough that this is no longer experimental. The trials are small, the protocols vary, but the direction is uniform.
Why “independent nursing intervention” matters
In hospital language, an intervention is anything a clinician does to change a clinical outcome. A medication is an intervention. A physiotherapy session is an intervention. A breathing exercise has, historically, been treated as adjacent to interventions, something patients might do at home with a mindfulness app, somewhere alongside the actual treatment.
Recommending pranayama as an independent nursing intervention reframes it. It says: this is a tool a nurse can teach during a treatment visit, not a referral to a yoga class. The dose, the protocol, and the outcome are specified clearly enough that they can sit inside a care pathway.
That framing is what allows a technique like Anuloma Viloma to be evaluated the same way any other supportive measure is evaluated. The 2025 BMC paper is part of a broader pattern. The same year, the International Journal of Research in Medical Sciences published a systematic review of 44 randomised controlled trials of alternate nostril breathing across multiple clinical and non-clinical populations and reported consistent positive outcomes on the autonomic nervous system, the cardiopulmonary system, and cognitive function.
This is not the wellness industry rediscovering its enthusiasm for breathing. This is clinical research catching up to a practice that yogic lineages have taught for a long time, and beginning to recommend it in the language hospitals use.
The specific technique the studies are pointing at
The breathing patterns named most often in the breast cancer literature are slow, structured, nasal techniques. Anuloma Viloma sits in the centre of that cluster. The practice is sometimes called Nadi Shodhana, which translates from Sanskrit as “purification of the channels.” Alternate nostril breathing is the western name. They refer to the same four-phase protocol: inhale through one nostril, hold, exhale through the other, hold, then reverse the sequence.
There is a reason this specific pattern keeps showing up in the studies. The four-phase rhythm produces a measurable pattern of vagal activation. The long exhale, paired with the brief retention after exhale, is the part of the cycle most strongly tied to parasympathetic dominance. The alternating nostrils slow the practice further than a single-passage breath can, which means the average breath rate during a five-minute session lands in the six-to-eight-breaths-per-minute range that the autonomic literature associates with the strongest heart-rate variability gains.
For a patient whose symptom burden includes nausea, fatigue, sleep disturbance, and distress, that combination is exactly the autonomic shift the body needs. Pranayama is not a metaphor for “calming down.” It is a structured physiological intervention.
What the protocol actually looks like
The BMC trial used a twice-daily, ten-minute session structure for 21 days. That is one specific dose. Other trials in the cluster have used five-minute sessions, or single-session designs to measure immediate physiological change. The shared feature is consistency of protocol: same technique, same ratio, same time of day.
The technique itself is small. Sit upright. Close the right nostril with the right thumb. Inhale slowly through the left nostril for a count of four. Close the left nostril with the right ring finger and hold for a count of two. Release the right nostril and exhale through it for a count of four. Hold empty for a count of two. Inhale through the right for a count of four. Hold. Close the right, open the left, exhale through the left for a count of four. Hold empty for a count of two. That is one round.
The ratio in the count is the part of the protocol that needs to stay consistent across sessions for the research-grade effects to show up. Four-two-four-two is a reasonable starting ratio. Many traditional curricula extend the exhale to be longer than the inhale (a four-two-eight-four ratio, for example) once the practitioner has settled into the technique. The choice is personal. The structure is the point.
Why a timer matters for a clinical population
A patient receiving chemotherapy is not reaching for a wellness app between treatments. They are managing fatigue, nausea, sleep disruption, and the cognitive fog that often comes with the regimen. A guided audio session, with a voice cueing each phase, can become one more thing competing for attention.
A timer is the quiet alternative. The four phases are named. The ratio is preserved. The audio stays silent unless the practitioner asks for haptic cues on the wrist. The practice runs itself.
For a researcher, the timer is also the thing that turns a personal practice into a reproducible protocol. The 2025 BMC trial’s “ten minutes twice daily for 21 days” recommendation is implementable as: open the app, set the ratio to four-two-four-two, run for ten minutes, twice a day. Two weeks later the practitioner stops thinking about counting and starts noticing what the practice does to sleep, appetite, and resting heart rate.
That is the same loop the trial measured. The timer is the bridge between the research protocol and the daily practice.
What this does not say
A few things this paper does not say, but that someone reading the headline alone might assume.
It does not say pranayama treats cancer. Chemotherapy treats cancer. The trial measured symptom burden during chemotherapy, not tumour response.
It does not say every patient will see the same reduction. The reported effect is a mean across the trial sample. Individual responses vary, and any patient considering adding a daily breathing practice during active treatment should mention it to their oncology team.
It does not say pranayama replaces psychological support, nutritional counselling, or any other component of supportive care. It says, narrowly, that a twice-daily structured breathing practice reduced measured symptom burden compared with routine care alone. That is the result. It is a useful one.
How to start
If a friend or family member is in active treatment and wants to try the practice that the BMC trial used, the entry point is small.
Sit upright, somewhere quiet. Five minutes is enough for the first week. Right thumb closes the right nostril. Inhale slowly through the left for four counts. Close the left with the right ring finger and hold for two. Release the right nostril, exhale through it for four. Hold empty for two. Inhale through the right for four. Hold for two. Close the right, exhale through the left for four. Hold empty for two. That is one full round.
After a few days the ratio becomes automatic and the counting moves into the background. The shoulders settle. The breath becomes quiet enough that someone in the next chair would not hear it.
The Anuloma Viloma Timer was built for this kind of practice. The four phases are named on screen, the ratio holds steady, and the haptics on the Apple Watch let a practitioner run a full session without looking at a phone. The free tier includes the complete Nadi Shodhana protocol. There is a subscription tier for richer customisation but the technique the BMC trial used does not require it.
A 2025 randomised controlled trial recommended pranayama as an independent nursing intervention for one of the most demanding clinical populations in modern medicine. That recommendation is unusual in the breathwork literature, and it is the right framing to keep in mind.
Anuloma Viloma Timer is free on the App Store. No subscription necessary.